Marjorie SidHoum

Market Access

Interview with Marjorie SidHoum at BIO Europe 2026

BIO-Europe Spring 2026: In conversation with Marjorie SidHou...

Marjorie SidHoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.

News

Wave's stock wavers on obesity drug data

Wave Life Sciences has said new clinical trial results with its non-incretin therapy for weight loss are positive – but investors don't seem to agree.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks